Vanda Pharmaceuticals (VNDA) Enterprise Value (2009 - 2026)
Vanda Pharmaceuticals recorded quarterly Enterprise Value of -$202.3 million in Q1 2026, up 23.32% quarter-over-quarter from -$263.8 million in Q4 2025, and up 40.66% year-over-year from -$143.8 million in Q1 2025.
Vanda Pharmaceuticals' Enterprise Value history runs 18 years deep, the most recent figure standing at -$202.3 million for Q1 2026.
- In Q1 2026, Enterprise Value rose 40.66% year-over-year to -$202.3 million; the TTM figure through Mar 2026 stood at -$202.3 million (up 40.66% YoY), while the FY2025 annual figure was -$263.8 million, up 29.57% from the prior year.
- Enterprise Value came in at -$202.3 million for Q1 2026 at Vanda Pharmaceuticals, up from -$263.8 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$202.3 million in Q1 2026 to a low of -$501.5 million in Q1 2023.
- A 5-year average of -$389.7 million and a median of -$388.3 million in 2023 frame the typical range for Enterprise Value.
- Across the five-year window, Enterprise Value fell 15.24% in 2023 and surged 40.66% in 2026, its largest moves.
- Vanda Pharmaceuticals' Enterprise Value stood at -$466.9 million in 2022, then grew by 16.83% to -$388.3 million in 2023, then increased by 3.51% to -$374.6 million in 2024, then grew by 29.57% to -$263.8 million in 2025, then increased by 23.32% to -$202.3 million in 2026.
- According to Business Quant data, Enterprise Value over the past three periods registered -$202.3 million, -$263.8 million, and -$293.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.32 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | -32.30 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -286.70 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | -61.46 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.77 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -7.25 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -18.44 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -8.75 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -3.01 Bn |
| 10 | Vanda Pharmaceuticals | 379.35 Mn | 177.04 Mn | 48.56 Mn | -202.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -202.31 Mn |
| Dec 31, 2025 | -263.85 Mn |
| Sep 30, 2025 | -293.75 Mn |
| Jun 30, 2025 | -325.55 Mn |
| Mar 31, 2025 | -340.91 Mn |
| Dec 31, 2024 | -374.64 Mn |
| Sep 30, 2024 | -376.26 Mn |
| Jun 30, 2024 | -387.68 Mn |
| Mar 31, 2024 | -394.14 Mn |
| Dec 31, 2023 | -388.26 Mn |
| Sep 30, 2023 | -489.86 Mn |
| Jun 30, 2023 | -489.35 Mn |
| Mar 31, 2023 | -501.50 Mn |
| Dec 31, 2022 | -466.86 Mn |
| Sep 30, 2022 | -454.79 Mn |
| Jun 30, 2022 | -440.86 Mn |
| Mar 31, 2022 | -435.18 Mn |
| Dec 31, 2021 | -432.81 Mn |
| Sep 30, 2021 | -405.97 Mn |
| Jun 30, 2021 | -396.49 Mn |
| Mar 31, 2021 | -378.16 Mn |
| Dec 31, 2020 | -367.74 Mn |
| Sep 30, 2020 | -348.55 Mn |
| Jun 30, 2020 | -339.85 Mn |
| Mar 31, 2020 | -312.33 Mn |
| Dec 31, 2019 | -312.13 Mn |
| Sep 30, 2019 | -237.79 Mn |
| Jun 30, 2019 | -280.16 Mn |
| Mar 31, 2019 | -267.84 Mn |
| Dec 31, 2018 | -257.36 Mn |
| Sep 30, 2018 | -240.58 Mn |
| Jun 30, 2018 | -231.22 Mn |
| Mar 31, 2018 | -248.83 Mn |
| Dec 31, 2017 | -143.41 Mn |
| Sep 30, 2017 | -139.88 Mn |
| Jun 30, 2017 | -137.12 Mn |
| Mar 31, 2017 | -137.76 Mn |
| Dec 31, 2016 | -201.83 Mn |
| Sep 30, 2016 | -142.58 Mn |
| Jun 30, 2016 | -135.99 Mn |
| Mar 31, 2016 | -138.33 Mn |
| Dec 31, 2015 | -143.18 Mn |
| Sep 30, 2015 | -144.32 Mn |
| Jun 30, 2015 | -146.64 Mn |
| Mar 31, 2015 | -134.33 Mn |
| Dec 31, 2014 | -129.82 Mn |
| Sep 30, 2014 | -56.09 Mn |
| Jun 30, 2014 | -63.59 Mn |
| Mar 31, 2014 | -100.40 Mn |
| Dec 31, 2013 | -130.35 Mn |
| Sep 30, 2013 | -142.17 Mn |
| Jun 30, 2013 | -103.63 Mn |
| Mar 31, 2013 | -110.93 Mn |
| Dec 31, 2012 | -120.40 Mn |
| Sep 30, 2012 | -134.40 Mn |
| Jun 30, 2012 | -144.70 Mn |
| Mar 31, 2012 | -157.25 Mn |
| Dec 31, 2011 | -148.88 Mn |
| Sep 30, 2011 | -161.45 Mn |
| Jun 30, 2011 | -188.40 Mn |
| Mar 31, 2011 | -52.52 Mn |
| Dec 31, 2010 | -198.04 Mn |
| Sep 30, 2010 | -102.47 Mn |
| Jun 30, 2010 | -145.65 Mn |
| Dec 31, 2009 | -205.30 Mn |